|Title||Identified metabolic signature for assessing red blood cell unit quality is associated with endothelial damage markers and clinical outcomes.|
|Publication Type||Journal Article|
|Year of Publication||2016|
|Authors||Bordbar A, Johansson PI, Paglia G, Harrison SJ, Wichuk K, Magnúsdóttir M, Valgeirsdottir S, Gybel-Brask M, Ostrowski SR, Palsson S, Rolfsson O, Sigurjónsson OE, Hansen MB, Gudmundsson S, Palsson BO|
BACKGROUND: There has been interest in determining whether older red blood cell (RBC) units have negative clinical effects. Numerous observational studies have shown that older RBC units are an independent factor for patient mortality. However, recently published randomized clinical trials have shown no difference of clinical outcome for patients receiving old or fresh RBCs. An overlooked but essential issue in assessing RBC unit quality and ultimately designing the necessary clinical trials is a metric for what constitutes an old or fresh RBC unit.
Identified metabolic signature for assessing red blood cell unit quality is associated with endothelial damage markers and clinical outcomes.